Drug-drug interactions: it is not only CYP450's which matter

被引：0
|
作者：
Back, David J. [1 ]
机构：
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
RETROVIROLOGY | 2010年 / 7卷
关键词：
Therapeutic Drug Monitoring; CYP450 Enzyme; Drug Disposition; Pharmacokinetic Drug; Sheer Number;
D O I：
10.1186/1742-4690-7-S1-I10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：4 / 4
页数：1
相关论文
共 50 条
  • [1] Drug-drug interactions: it is not only CYP450's which matter
    David J Back
    Retrovirology, 7
  • [2] Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug-drug interactions: a PharmacoVigilance study in France
    Danton, Anne Charlotte
    Montastruc, Francois
    Sommet, Agnes
    Durrieu, Genevieve
    Bagheri, Haleh
    Bondon-Guitton, Emmanuelle
    Lapeyre-Mestre, Maryse
    Montastruc, Jean-Louis
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (04) : 885 - 888
  • [3] CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver
    Rey-Bedon, Camilo
    Banik, Peony
    Gokaltun, Aslihan
    Hofheinz, O.
    Yarmush, Martin. L.
    Uygun, M. Korkut
    Usta, O. Berk
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 146
  • [4] Biology of Heme: Drug Interactions and Adverse Drug Reactions with CYP450
    Kumar, Neeraj
    Chugh, Heerak
    Sood, Damini
    Singh, Snigdha
    Singh, Aarushi
    Awasthi, Amar Deep
    Tomar, Ravi
    Tomar, Vartika
    Chandra, Ramesh
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (23) : 2042 - 2055
  • [5] Re: Pergolizzi et al. 2011: Exposure to potential CYP450 pharmacokinetic drug-drug interactions
    Nieminen, Tuija H.
    Hagelberg, Nora M.
    Saari, Teijo I.
    Gronlund, Juha
    Neuvonen, Pertti J.
    Olkkola, Klaus T.
    PAIN PRACTICE, 2012, 12 (01) : 81 - 82
  • [6] Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice
    Deodhar, Malavika
    Al Rihani, Sweilem B.
    Arwood, Meghan J.
    Darakjian, Lucy
    Dow, Pamela
    Turgeon, Jacques
    Michaud, Veronique
    PHARMACEUTICS, 2020, 12 (09) : 1 - 18
  • [7] Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
    Pergolizzi, Joseph V., Jr.
    Labhsetwar, Sumedha A.
    Puenpatom, R. Amy
    Joo, Seongjung
    Ben-Joseph, Rami
    Summers, Kent H.
    PAIN PRACTICE, 2011, 11 (04) : 325 - 336
  • [8] Computational drug-drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel
    Ananthathandavan, Priyadharshini
    Narayanasamy, Damodharan
    FUTURE SCIENCE OA, 2024, 10 (01):
  • [9] Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery
    Krippendorff, Ben-Fillippo
    Lienau, Philip
    Reichel, Andreas
    Huisinga, Wilhelm
    JOURNAL OF BIOMOLECULAR SCREENING, 2007, 12 (01) : 92 - 99
  • [10] PREDICTING THE POTENTIAL FOR CANNABIDIOL INDUCED DRUG-DRUG INTERACTIONS WITH MAJOR CYP450 ENZYMES USING MODEL-BASED APPROACHES
    Eltanameli, B.
    Al Sahlawi, S.
    Cicali, B.
    Cristofoletti, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S37 - S38
12345